Detlev Corsepius

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.

Vivantes-Netzwerk für Gesundheit GmbH is a hospital operating company based in Berlin, Germany. The German company operates hospitals and is ultimately controlled by the City of Berlin. The CEO of the company is Andrea Grebe.

Part of Novartis AG, Roche Diagnostics AG is a Swiss healthcare company committed to improving lives through innovative medicines and diagnostic tests. The company is based in Rotkreuz, Switzerland. Roche has been a pioneer in healthcare since its founding in 1896 and has helped millions of patients worldwide.

Part of Roche Holding AG, Roche Diagnostics Scandinavia AB is a company that provides health care services. The company is based in Solna, Sweden. Matthew Sause has been the CEO of the Swedish company since 2023.

Charité Research Organisation GmbH is a contract research organization that helps clients move development projects from first time in human to proof of concept as quickly and efficiently as possible. The private company is based in Berlin, Germany and was founded in 2005 by Frank Wagner, who has been the CEO since then. Charité Research Organisation offers scientific and regulatory consultancy, protocol development, routine laboratory, biomarker laboratory, imaging, project management, monitoring, data management, biostatistics, and medical writing services. The German company also provides world-leading patient and healthy volunteer recruitment capabilities and delivers the best value solution for early clinical development.

Vivantes Ida-Wolff-Krankenhaus GmbH is a private company based in Berlin, Germany. The CEOs of the German company are Andrea Grebe, Johannes Danckert.

Vivantes - MVZ GmbH is a medical center based in Berlin, Germany, with CEOs Andrea Grebe and Axel Roesler. The German company provides outpatient care for gastroenterological, hepatological, and psychological diseases, as well as primary care. The medical centers of Vivantes offer both general and specialized medical care. The company is ultimately controlled by the City of Berlin.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.

Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker.